Posterior reversible encephalopathy syndrome: A review

Critical Care and Shock

Volumn 12, Issue 4, 2009, Pages 135-143

  Pedraza, Rodrigo ^a   Marik, Paul E ^b   Varon, Joseph ^c,d,e  

^a University of Tamaulipas   (Mexico)

^b THOMAS JEFFERSON UNIVERSITY   (United States)

^c UNIVERSITY OF TEXAS   (United States)

^d ST LUKE S EPISCOPAL HOSPITAL   (United States)

^e UNIVERSITY OF TEXAS MEDICAL BRANCH   (United States)

Author keywords

Eclampsia; Hypertensive crisis; Hypertensive emergency; Immunosuppressants; Reversible encephalopathy

Indexed keywords

CYCLOSPORIN; GEMCITABINE; IMMUNOSUPPRESSIVE AGENT; MIDODRINE; OXALIPLATIN;

EDEMA; HEADACHE; HELLP SYNDROME; HUMAN; HYPERTENSION ENCEPHALOPATHY; NUCLEAR MAGNETIC RESONANCE; POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME; PREECLAMPSIA; PREGNANCY; REVIEW;

EID: 77949779361     PISSN: 14107767     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (55)

1. Lim MH, Kim DW, Cho HS, Lee HJ, Kim HJ, Park KJ, et al. Isolated cerebellar reversible leukoencephalopathy syndrome in a patient with end stage renal disease. Intern Med 2008;47:43-5.
2. Hinchey J, Chaves C, Appignani B, Breen J, Pao L, Wang A, et al. A reversible posterior leukoencephalopathy syndrome. N Engl J Med 1996;334:494-500.
3. Kozak OS, Wijdicks EF, Manno EM, Miley JT, Rabinstein AA. Status epilepticus as initial manifestation of posterior reversible encephalopathy syndrome. Neurology 2007;69:894-7.
4. Ishikura K, Ikeda M, Hamasaki Y, Hataya H, Nishimura G, Hiramoto R, et al. Nephrotic state as a risk factor for developing posterior reversible encephalopathy syndrome in paediatric patients with nephrotic syndrome. Nephrol Dial Transplant 2008;23:2531-6.
5. Bartynski WS, Boardman JF, Zeigler ZR, Shadduck RK, Lister J. Posterior reversible encephalopathy syndrome in infection, sepsis, and shock. AJNR Am J Neuroradiol 2006;27:2179-90.
6. El Karoui K, Le Quintrec M, Dekeyser E, Servais A, Hummel A, Fadel F, et al. Posterior reversible encephalopathy syndrome in systemic lupus erythematosus. Nephrol Dial Transplant 2008;23:757-63.
7. Marik PE, Varon J. Hypertensive crises: challenges and management. Chest 2007;131:1949-62.
8. Vaughan CJ, Delanty N. Hypertensive emergencies. Lancet 2000;356:411-7.
9. Kwon S, Koo J, Lee S. Clinical spectrum of reversible posterior leukoencephalopathy syndrome. Pediatr Neurol 2001;24:361-4.
10. Doi Y, Kimura F, Fujiyama T, Fujimura C, Nishina T, Sato T, et al. Hypertensive brainstem encephalopathy without parietooccipital lesion - two case reports. Neurol Med Chir (Tokyo) 2006;46:75-9.
11. Alehan F, Erol I, Agildere AM, Ozcay F, Baskin E, Cengiz N, et al. Posterior leukoencephalopathy syndrome in children and adolescents. J Child Neurol 2007;22:406-13.
12. McKinney AM, Short J, Truwit CL, McKinney ZJ, Kozak OS, SantaCruz KS, et al. Posterior reversible encephalopathy syndrome: incidence of atypical regions of involvement and imaging findings. AJR Am J Roentgenol 2007;189:904-12.
13. Yano Y, Kario K, Fukunaga T, Ohshita T, Himeji D, Yano M, et al. A case of reversible posterior leukoencephalopathy syndrome caused by transient hypercoagulable state induced by infection. Hypertens Res 2005;28:619-23.
14. Cipolla MJ. Cerebrovascular function in pregnancy and eclampsia. Hypertension 2007;50:14-24.
15. Kontos HA, Wei EP, Navari RM, Levasseur JE, Rosenblum WI, Patterson JL Jr. Responses of cerebral arteries and arterioles to acute hypotension and hypertension. Am J Physiol 1978;234:H371-83.
16. Peng WX, Nakaii M, Matsushima T, Asakura H. Atypical case of reversible posterior leucoencephalopathy syndrome associated with puerperal HELLP syndrome. Arch Gynecol Obstet 2008;278:269-71.
17. Morelli N, Gori S, Michelassi MC, Falorni M, Cafforio G, Bianchi MC, et al. Atypical posterior reversible encephalopathy syndrome in puerperium. Eur Neurol 2008;59:195-7.
18. Covarrubias DJ, Luetmer PH, Campeau NG. Posterior reversible encephalopathy syndrome: prognostic utility of quantitative diffusion-weighted MR images. AJNR Am J Neuroradiol 2002;23:1038-48.
19. Doelken M, Lanz S, Rennert J, Alibek S, Richter G, Doerfler A. Differentiation of cytotoxic and vasogenic edema in a patient with reversible posterior leukoencephalopathy syndrome using diffusion-weighted MRI. Diagn Interv Radiol 2007;13:125-8.
20. Kapiteijn E, Brand A, Kroep J, Gelderblom H. Sunitinib induced hypertension, thrombotic microangiopathy and reversible posterior leukencephalopathy syndrome. Ann Oncol 2007;18:1745-7.
21. Cipolla MJ, Vitullo L, McKinnon J. Cerebral artery reactivity changes during pregnancy and the postpartum period: a role in eclampsia? Am J Physiol Heart Circ Physiol 2004;286:H2127-32.
22. Aukes AM, Vitullo L, Zeeman GG, Cipolla MJ. Pregnancy prevents hypertensive remodeling and decreases myogenic reactivity in posterior cerebral arteries from Dahl salt-sensitive rats: a role in eclampsia? Am J Physiol Heart Circ Physiol 2007;292:H1071-6.
23. Levine RJ, Maynard SE, Qian C, Lim KH, England LJ, Yu KF, et al. Circulating angiogenic factors and the risk of preeclampsia. N Engl J Med 2004;350:672-83.
24. El Maalouf G, Mitry E, Lacout A, Lièvre A, Rougier P. Isolated brainstem involvement in posterior reversible leukoencephalopathy induced by bevacizumab. J Neurol 2008;255:295-6.
25. Rajasekhar A, George TJ Jr. Gemcitabine-induced reversible posterior leukoencephalopathy syndrome: a case report and review of the literature. Oncologist 2007;12:1332-5.
26. Yokobori S, Yokota H, Yamamoto Y. Pediatric posterior reversible leukoencephalopathy syndrome and NSAID-induced acute tubular interstitial nephritis. Pediatr Neurol 2006;34:245-7.
27. Kim JS, Lee KS, Lim SC, Ahn JY, Song IU, Kim YI, et al. Reversible posterior leukoencephalopathy syndrome in a patient with multiple system atrophy: a possible association with oral midodrine treatment. Mov Disord 2007;22:1043-6.
28. Pinedo DM, Shah-Khan F, Shah PC. Reversible posterior leukoencephalopathy syndrome associated with oxaliplatin. J Clin Oncol 2007;25:5320-1.
29. Irvin W, MacDonald G, Smith JK, Kim WY. Dexamethasone-induced posterior reversible encephalopathy syndrome. J Clin Oncol 2007;25:2484-6.
30. Bodkin CL, Eidelman BH. Sirolimusinduced posterior reversible encephalopathy. Neurology 2007;68:2039-40.
31. Lyson T, McMullan DM, Ermel LD, Morgan BJ, Victor RG. Mechanism of cyclosporine-induced sympathetic activation and acute hypertension in rats. Hypertension 1994;23:667-75.
32. Schwartz RB, Feske SK, Polak JF, DeGirolami U, Iaia A, Beckner KM, et al. Preeclampsiaeclampsia: clinical and neuroradiographic correlates and insights into the pathogenesis of hypertensive encephalopathy. Radiology 2000;217:371-6.
33. Sweany JM, Bartynski WS, Boardman JF. "Recurrent" posterior reversible encephalopathy syndrome: report of 3 cases--PRES can strike twice! J Comput Assist Tomogr 2007;31:148-56.
34. Mutunga M, Fulton B, Bullock R, Batchelor A, Gascoigne A, Gillespie JI, et al. Circulating endothelial cells in patients with septic shock. Am J Respir Crit Care Med 2001;163:195-200.
35. McCuskey RS, Urbaschek R, Urbaschek B. The microcirculation during endotoxemia. Cardiovasc Res 1996;32:752-63.
36. Prasad N, Gulati S, Gupta RK, Sharma K, Gulati K, Sharma RK, et al. Spectrum of radiological changes in hypertensive children with reversible posterior leucoencephalopathy. Br J Radiol 2007;80:422-9.
37. Tanioka R, Yamamoto Y, Sakai M, Makie T, Mori M, Uehira T, et al. Convalescence of atypical reversible posterior leukoencephalopathy syndrome in human immunodeficiency virus infection. J Med Invest 2007;54:191-4.
38. Okeda R, Kawamoto T, Tanaka E, Shimizu H. An autopsy case of drug-induced diffuse cerebral axonopathic leukoencephalopathy: the pathogenesis in relation to reversible posterior leukoencephalopathy syndrome. Neuropathology 2007;27:364-70.
39. Mak A, Chan BP, Yeh IB, Ho RC, Boey ML, Feng PH, et al. Neuropsychiatric lupus and reversible posterior leucoencephalopathy syndrome: a challenging clinical dilemma. Rheumatology (Oxford) 2008;47:256-62.
40. Saeed MU, Dacuycuy MA, Kennedy DJ. Posterior reversible encephalopathy syndrome in HIV patients: case report and review of the literature. AIDS 2007;21:781-2.
41. Bartynski WS, Boardman JF. Distinct imaging patterns and lesion distribution in posterior reversible encephalopathy syndrome. AJNR Am J Neuroradiol 2007;28:1320-7.
42. Varon J. Treatment of acute severe hypertension: current and newer agents. Drugs 2008;68:283-97.
43. Varon J, Marik PE. Clinical review: the management of hypertensive crises. Crit Care 2003;7:374-84.
44. Lowe SA, Brown MA, Dekker GA, Gatt S, McLintock CK, McMahon LP, et al. Guidelines for the management of hypertensive disorders of pregnancy 2008. Aust N Z J Obstet Gynaecol 2009;49:242-6.
45. Duley L, Henderson-Smart DJ. Drugs for treatment of very high blood pressure during pregnancy. Cochrane Database Syst Rev 2002:CD001449.
46. Duley L, Gulmezoglu AM. Magnesium sulphate versus lytic cocktail for eclampsia. Cochrane Database Syst Rev 2001:CD002960.
47. Duley L, Henderson-Smart D. Magnesium sulphate versus phenytoin for eclampsia. Cochrane Database Syst Rev 2003:CD000128.
48. Duley L, Henderson-Smart D. Magnesium sulphate versus diazepam for eclampsia. Cochrane Database Syst Rev 2003:CD000127.
49. Lowenstein DH, Bleck T, Macdonald RL. It's time to revise the definition of status epilepticus. Epilepsia 1999;40:120-2.
50. Marik PE, Varon J. The management of status epilepticus. Chest 2004;126:582-91.
51. Alldredge BK, Gelb AM, Isaacs SM, Corry MD, Allen F, Ulrich S, et al. A comparison of lorazepam, diazepam, and placebo for the treatment of out-of-hospital status epilepticus. N Engl J Med 2001;345:631-7.
52. Lowenstein DH, Alldredge BK. Status epilepticus. N Engl J Med 1998;338:970-6.
53. Rossetti AO, Logroscino G, Bromfield EB. Refractory status epilepticus: effect of treatment aggressiveness on prognosis. Arch Neurol 2005;62:1698-702.
54. Claassen J, Hirsch LJ, Emerson RG, Mayer SA. Treatment of refractory status epilepticus with pentobarbital, propofol, or midazolam: a systematic review. Epilepsia 2002;43:146-53.
55. Lee SY, Dinesh SK, Thomas J. Hypertension-induced reversible posterior leukoencephalopathy syndrome causing obstructive hydrocephalus. J Clin Neurosci 2008;15:457-9.